YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition

被引：0
|
作者：
Xiangyuan Luo
Mengdie Cao
Fan Gao
Xingxing He
机构：
[1] Huazhong University of Science and Technology,Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College
[2] Huazhong University of Science and Technology,Hubei Key Laboratory of Hepato
来源：
Experimental Hematology & Oncology | / 10卷
关键词：
Liver cancer; YTHDF1; m; A; PI3K/AKT/mTOR; EMT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
    Luo, Xiangyuan
    Cao, Mengdie
    Gao, Fan
    He, Xingxing
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [2] Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway
    Luo, Xue
    Wang, Jinping
    Lu, Jinxi
    Wang, Xi
    Miao, Yuan
    Li, Qingchang
    Li, Xiaoman
    Wang, Liang
    [J]. BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [3] STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2
    Zhang, Dong
    Liu, Haitao
    Wang, Weihua
    Xu, Gang
    Yin, Chenxiao
    Wang, Songgang
    [J]. CANCER BIOLOGY & THERAPY, 2022, 23 (01) : 1 - 16
  • [4] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhenyu Zhang
    Jinfeng Zhu
    Yansong Huang
    Weibing Li
    Hongqiu Cheng
    [J]. Diagnostic Pathology, 13
  • [5] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhang, Zhenyu
    Zhu, Jinfeng
    Huang, Yansong
    Li, Weibing
    Cheng, Hongqiu
    [J]. DIAGNOSTIC PATHOLOGY, 2018, 13
  • [6] VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
    Zhangya Pu
    Dan G. Duda
    Yuanyuan Zhu
    Siya Pei
    Xiaofang Wang
    Yan Huang
    Panpan Yi
    Zebing Huang
    Fang Peng
    Xingwang Hu
    Xuegong Fan
    [J]. Journal of Translational Medicine, 20
  • [7] VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
    Pu, Zhangya
    Duda, Dan G.
    Zhu, Yuanyuan
    Pei, Siya
    Wang, Xiaofang
    Huang, Yan
    Yi, Panpan
    Huang, Zebing
    Peng, Fang
    Hu, Xingwang
    Fan, Xuegong
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [8] A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
    Xu, Wenting
    Yang, Zhen
    Lu, Nonghua
    [J]. CELL ADHESION & MIGRATION, 2015, 9 (04) : 317 - 324
  • [9] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
    Yu, Xinxin
    Zheng, Yan
    Zhu, Xuchao
    Gao, Xiaomei
    Wang, Chaoqun
    Sheng, Yuanyuan
    Cheng, Wei
    Qin, Lunxiu
    Ren, Ning
    Jia, Huliang
    Dong, Qiongzhu
    [J]. ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
  • [10] CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling Pathway
    Zang, Mingde
    Zhang, Baogui
    Zhang, Yunqiang
    Li, Jianfang
    Su, Liping
    Zhu, Zhenggang
    Gu, Qinlong
    Liu, Bingya
    Yan, Min
    [J]. PLOS ONE, 2014, 9 (11):
12345